Guangzhou KOFA Biotechnology Co., Ltd

Product Name:  H-FABP Reagent Kit (Quantitative)

Method: Laternal-Flow technology (Fluorescent Immunochromatographic)

Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box

Registration NO.: 20152400175 by CFDA

Certificates: CE, SGS ISO13485, ISO9001

Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd.
 

Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of H-FABP level in the serum/plasma. H-FABP can be applied to detect the early myocardial injury, evaluate the area of myocardial infraction and the effect of reperfusion injury.

KOFA H-FABP Technical Parameters:

The advantages of KOFA H-FABP

1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of H-FABP level available

2. Low cost and rapid test, can get the quantitative and reliable results in 15minutes, shorten the testing turnaround time.

3. The testing results from KOFA H-FABP has good correlation with that of Roche Diagnostics (compared with thousands of cases)

4. Simple operation and rapid test, can meet the need of various departments.

5. H-FABP can be applied to the detection of hyperacute period myocardial infraction, and it is the sensitive indicator for the diagnosis of the patients that should be hospitalized and accept coronary angiography and interventional treatment especially for the early diagnosis and prognosis of the patients with chest pain in 6 hours.

Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, obstetrics, pediatrics, emergency ward and ICU.